|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Net amortization of (discounts) premiums on investment securities | |||||
| Provision for credit losses | |||||
| Share-based compensation | |||||
| Provision for litigation settlement | |||||
| Deferred income tax expense (benefit) | |||||
| Proceeds from sale of loans held for sale | |||||
| Originations of loans held for sale | |||||
| Income on company owned life insurance | |||||
| Net gain on sale of loans held for sale | |||||
| Net (gain) loss on sale of investment securities | |||||
| Net loss (gain) on other assets | |||||
| Net gain on sale of assets of subsidiary | |||||
| Net loss on other assets | |||||
| Total net loss (gain) on other assets | |||||
| Restructuring charges | |||||
| Decrease (increase) in other assets | |||||
| (Decrease) increase in other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of available for sale securities | |||||
| Purchases of held to maturity securities | |||||
| Proceeds from principal payments, maturities and calls on available for sale securities | |||||
| Proceeds from principal payments, maturities and calls on held to maturity securities | |||||
| Proceeds from sales of securities available for sale | |||||
| Net increase in loans | |||||
| Purchase of company owned life insurance, net of benefits received | |||||
| Proceeds from surrender of company owned life insurance | |||||
| Proceeds from sales of other assets | |||||
| Proceeds from sale of assets of subsidiary | |||||
| Proceeds from sale of other assets | |||||
| Purchases of premises and equipment | |||||
| Cash consideration paid for acquisition, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net increase (decrease) in deposits | |||||
| Net (decrease) increase in short-term borrowings | |||||
| More than three months - borrowings | |||||
| 'More than three months - repayments | |||||
| 'Three months or less, net | |||||
| Total net (decrease) increase in short-term borrowings | |||||
| Repurchase of preferred stock | |||||
| Issuance of long-term borrowings | |||||
| Payment of long-term borrowings | |||||
| Long-term borrowing issuance costs | |||||
| Purchases of common stock for treasury | |||||
| Cash dividends paid to preferred shareholders | |||||
| Cash dividends paid to common shareholders | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
Loading...